Alibaba and Baidu stand to benefit because China will not slow its AI development even if the US slows its own. x.com 

Alibaba is a contrarian trade because accelerating demand for relatively cheaper compute is very underappreciated, and China's cloud market is still in its infancy versus the US. Alibaba is a consensus short as upside from closed-source AI looks illusory. x.com  x.com 

Alibaba's HK$80 billion share sale looks like a grab-the-money-and-run move before the AI party ends, with base rates set to go ballistic as in 1972-1973. @AKL_019 notes the HK$112.70 price is 39.5% below the 52-week high, and asks why it didn't raise money in late 2025 or early 2026. @stevehou notes Alibaba is selling stock for AI without new highs or market validation of its AI efforts. In capital markets, the stupid but practical reason is usually the right one, as with SpaceX's fundraising. … Show more

Alibaba's Qwen models look able to beat costlier US AI: two weeks of testing showed no difference from US AI agents, at 80% less per token. US companies spending hundreds of billions and driving up compute costs risk losing the battle to cheaper Chinese models. A selloff to the low $100s would be a chance to buy much more. x.com 

China reportedly restricted overseas travel for key AI talent at Alibaba and DeepSeek, a sign Beijing sees them as its two most strategic AI assets, and Alibaba could deliver surprises over the next couple of months. US tech has outperformed, but the bad news looks baked in, and any Chinese surprise could send Alibaba to the stratosphere. x.com  x.com 

Alibaba is tough to hold because it is splitting investment between e-commerce and AI, creating massive execution risk. AI is so capex-hungry that, as Western examples show, Alibaba cannot spread spending and still reach comparable results. The market sees China e-commerce spending, including the quick-commerce race, as having no ROI, and is right. Replies argue Alibaba has no choice; it might still make it, but the risk is that its AI push slows. x.com  x.com  x.com 

Alibaba is a sleeper AI winner: AliCloud external revenue grew 40% last quarter, and AI product revenue posted its 11th straight quarter of triple-digit growth. Its roughly 5% CXMT stake, bought for 7.6B yuan, is now worth over $20B. The main risk is distillation: Anthropic raised Qwen with Senate Banking in June, and the administration said in April it would act on Chinese labs pulling from US models. Alibaba denies it, but that is a headline waiting to hit. x.com  x.com  x.com 

Alibaba and Baidu are a no-brainer buy because Chinese AI stocks trade at very low valuations while China is determined to race the US in AI. x.com 

Anthropic's accusation that Alibaba's Qwen lab distilled its frontier models is optically bearish for Alibaba, though no penalties have been enforced. Per Anthropic, the lab used thousands of fake accounts and over 28.8 million exchanges. While penalties are absent, the rewards outweigh the risks for Alibaba if distillation lifts Qwen's market share, as many US AI startups already use Qwen for its cost-effectiveness versus Gemini and others. x.com  x.com 

Alibaba is the cleanest public-market bet that Chinese AI labs are innovating rather than just distilling, and that cheaper models drive more usage. If China is innovating, Qwen drives Alibaba Cloud share; if Jevons paradox holds, Alibaba captures the spend across models, compute, data, chips and apps. AI products are already 30% of Alibaba Cloud's external revenue, above a $5B run rate, and the commerce cash engine can carry it through the capex/revenue mismatch. x.com